Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers (HIMS) or Sarepta (SRPT) To Contact Him Directly To Discuss Their Options
So here we are again, witnessing President Trump’s grandiose trade war escapades, now targeting the European Union with a fresh batch of tariffs. The...
Ah, the delightful spectacle of tariffs—a little economic theater where everyone pretends that taxing imports is the pinnacle of strategic genius. President Trump, in...
BIRMINGHAM, Ala. and CLEVELAND, Tenn., July 18, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation...
Rail Workers, Union Leaders, Elected Officials Shine Spotlight on Rail Safety
COLUMBIANA, Ohio, July 18, 2025 /PRNewswire/ -- At 12 p.m. on Saturday, July 19,...
Partnership with Louis Hernandez Jr, For A Bright Future Foundation, has a long history of supporting equal access to healthcare for communities around the...
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
AB Akola Group, an investment company that owns one of the largest agricultural and food production groups in the Baltic States, has temporarily postponed the construction of a biomethane gas production plant in the Kaišiadorys district through its indirectly controlled company AB Kaišiadorių paukštynas. This investment project remains part of AB Akola Group's long-term development plans.
The Board of Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) approved unaudited Telia Lietuva, AB Interim Financial Statements, prepared according to International Financial Reporting Standards as adopted by the European Union, for 6 months’ period ended 30 June 2025.